HEALTH
- Share via
<i> Times Staff And Wire Reports</i>
Syntex to Cut Staff: The company, acquired last year by Roche Pharmaceuticals of Switzerland, has announced plans to reduce its Palo Alto work force by about 800. In its announcement, Syntex Corp. said laid-off employees will receive severance pay and benefits based on length of service. All of the layoffs are expected by year’s end. Syntex, which will change its name to Roche Bioscience this summer, will be left with about 1,000 employees, a spokeswoman said.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.